B-Type natriuretic peptide suppression of neutrophil superoxide generation: Mechanistic studies in normal subjects

Clinical and Experimental Pharmacology and Physiology

Volumn 41, Issue 10, 2014, Pages 739-743

  Liu, Saifei ^a   Ngo, Doan Tm ^a   Stewart, Simon ^b   Horowitz, John D ^a   Chirkov, Yuliy Y ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

B type natriuretic peptide; cGMP; Myeloperoxidase; Neutrophils; Protein kinase G; Superoxide

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CYCLIC GMP DEPENDENT PROTEIN KINASE; FORMYLMETHIONYLLEUCYLPHENYLALANINE; PHORBOL 13 ACETATE 12 MYRISTATE; SUPEROXIDE; CARBAZOLE DERIVATIVE; CPT-CGMP; CYCLIC GMP; KT 5823; PEROXIDASE;

ADULT; ARTICLE; CELL PERMEABILIZATION; CONTROLLED STUDY; ELECTRON SPIN RESONANCE; ENZYME INHIBITION; HUMAN; HUMAN CELL; NEUTROPHIL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; ANALOGS AND DERIVATIVES; DRUG EFFECTS; METABOLISM;

CARBAZOLES; CYCLIC GMP; CYCLIC GMP-DEPENDENT PROTEIN KINASES; HUMANS; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NATRIURETIC PEPTIDE, BRAIN; NEUTROPHILS; PEROXIDASE; SUPEROXIDES; TETRADECANOYLPHORBOL ACETATE;

EID: 84911049579     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/1440-1681.12291     Document Type: Article

References (22)

1. Goldmann BU, Rudolph V, Rudolph TK et al. Neutrophil activation precedes myocardial injury in patients with acute myocardial infarction. Free Radic. Biol. Med. 2009; 47: 79-83.
2. Friedrichs K, Adam M, Remane L et al. Induction of atrial fibrillation by neutrophils critically depends on CD11b/CD18 integrins. PLoS ONE 2014; 9: e89307.
3. Weiss SJ. Tissue destruction by neutrophils. N. Engl. J. Med. 1989; 320: 365-76.
4. Clancy RM, Leszczynska-Piziak J, Abramson SB. Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase. J. Clin. Invest. 1992; 90: 1116-21.
5. Moilanen E, Vuorinen P, Kankaanranta H, Metsa-Ketela T, Vapaatalo H. Inhibition by nitric oxide-donors of human polymorphonuclear leucocyte functions. Br. J. Pharmacol. 1993; 109: 852-8.
6. Cowie MR, Mendez GF. BNP and congestive heart failure. Prog. Cardiovasc. Dis. 2002; 44: 293-321.
7. Ogawa T, de Bold AJ. Brain natriuretic peptide production and secretion in inflammation. J. Transplant. 2012; 2012: 962347.
8. Kellett J. Prediction of mortality of patients with suspected heart failure by brain natriuretic peptide concentrations >100 pg/mL: Comparison of a clinical model with brain natriuretic peptide concentrations. Heart 2006; 92: 1512-3.
9. Wyatt TA, Lincoln TM, Pryzwansky KB. Regulation of human neutrophil degranulation by LY-83583 and l-arginine: Role of cGMP-dependent protein kinase. Am. J. Physiol. 1993; 265: C201-11.
10. Werner CG, Godfrey V, Arnold RR et al. Neutrophil dysfunction in guanosine 3', 5'-cyclic monophosphate-dependent protein kinase I-deficient mice. J. Immunol. 2005; 175: 1919-29.
11. Ervens J, Schultz G, Seifert R. Differential inhibition and potentiation of chemoattractant-induced superoxide formation in human neutrophils by the cell-permeant analogue of cyclic GMP, N2, 2'-O-dibutyryl guanosine 3':5'-cyclic monophosphate. Naunyn Schmiedebergs Arch. Pharmacol. 1991; 343: 370-6.
12. Wenzel-Seifert K, Ervens J, Seifert R. Differential inhibition and potentiation by cell-permeant analogues of cyclic AMP and cyclic GMP and NO-containing compounds of exocytosis in human neutrophils. Naunyn Schmiedebergs Arch. Pharmacol. 1991; 344: 396-402.
13. Matsumura T, Kugiyama K, Sugiyama S et al. Neutral endopeptidase 24.11 in neutrophils modulates protective effects of natriuretic peptides against neutrophils-induced endothelial cytotoxity. J. Clin. Invest. 1996; 97: 2192-203.
14. Wiedermann CJ, Niedermuhlbichler M, Braunsteiner H, Widermann CJ. Priming of polymorphonuclear neutrophils by atrial natriuretic peptide in vitro. J. Clin. Invest. 1992; 89: 1580-6.
15. Su J, Scholz PM, Weiss HR. Differential effects of cGMP produced by soluble and particulate guanylyl cyclase on mouse ventricular myocytes. Exp. Biol. Med. 2005; 230: 242-50.
16. Piggott LA, Hassell KA, Berkova Z, Morris AP, Silberbach M, Rich TC. Natriuretic peptides and nitric oxide stimulate cGMP synthesis in different cellular compartments. J. Gen. Physiol. 2006; 128: 3-14.
17. Maisel A. B-Type natriuretic peptide levels: Diagnostic and prognostic in congestive heart failure: What's next? Circulation 2002; 105: 2328-31.
18. Lin EQ, Irvine JC, Cao AH et al. Nitroxyl (HNO) stimulates soluble guanylyl cyclase to suppress cardiomyocyte hypertrophy and superoxide generation. PLoS ONE 2012; 7: e34892.
19. Laskowski A, Woodman OL, Cao AH et al. Antioxidant actions contribute to the antihypertrophic effects of atrial natriuretic peptide in neonatal rat cardiomyocytes. Cardiovasc. Res. 2006; 72: 112-23.
20. Liu FC, Day YJ, Liou JT, Yu HP, Liao HR. Splitomicin inhibits fMLP-induced superoxide anion production in human neutrophils by activate cAMP/PKA signaling inhibition of ERK pathway. Eur. J. Pharmacol. 2012; 688: 68-75.
21. Dikalov SI, Dikalova AE, Mason RP. Noninvasive diagnostic tool for inflammation-induced oxidative stress using electron spin resonance spectroscopy and an extracellular cyclic hydroxylamine. Arch. Biochem. Biophys. 2002; 402: 218-26.
22. Rosen GM, Finkelstein E, Rauckman EJ. A method for the detection of superoxide in biological systems. Arch. Biochem. Biophys. 1982; 215: 367-78.